bf/NASDAQ:VTGN_icon.png

COM:VISTAGEN

Vistagen Therapeutics, Inc

  • Stock

Last Close

3.09

31/10 20:00

Market Cap

83.33M

Beta: -

Volume Today

196.03K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
asset turnover
0.34
-
0.01
-
0.01
47.65%
-0.01
172.55%
0.01
179.84%
cash per share
-0.16
-
1.59
1,071.97%
7.27
356.63%
11.64
60.03%
22.42
92.64%
13.76
38.61%
0.93
93.27%
35.91
3,775.36%
0.34
99.04%
0.00
99.31%
0.01
157.52%
company equity multiplier
-0.02
-
-0.01
36.27%
-0.33
2,432.32%
6.03
1,913.23%
1.63
72.95%
1.98
21.45%
-1.01
150.87%
1.18
216.85%
1.15
2.02%
1.75
51.36%
1.08
38.02%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
13.60
-
111.22
717.71%
-1.29K
1,258.93%
dividend yield
85.15
-
79.77
6.32%
30.01
62.38%
65.46
118.16%
7.55
88.46%
0.13
98.30%
0.03
73.03%
ebit per revenue
-8.20
-
-16.46
-
-43.09
161.76%
260.75
705.17%
-31.03
111.90%
ebt per ebit
0.59
-
2.05
247.46%
2.65
29.13%
1.00
62.18%
1.01
0.97%
1.00
0.88%
1.00
0.27%
1.00
0.13%
1.00
0.03%
1.00
0.00%
0.89
11.05%
effective tax rate
-0.00
-
-0.00
81.02%
-0.00
71.82%
-0.00
380.55%
-0.00
28.52%
-0.00
36.80%
-0.00
18.37%
-0.00
15.84%
-0.00
50.90%
-0.00
39.89%
enterprise value multiple
-3.43
-
-4.00
16.54%
-0.85
78.77%
-1.17
37.61%
-0.18
84.30%
-1.02
456.53%
-1.07
4.51%
-4.72
342.60%
-155.92
3,201.34%
-422.45
170.93%
-3.16K
648.39%
fixed asset turnover
4.36
-
0.30
-
0.36
18.68%
-0.08
122.78%
0.47
674.51%
free cash flow per share
-58.31
-
-62.99
8.02%
-82.04
30.25%
-29.88
63.58%
-19.57
34.51%
-15.44
21.09%
-10.78
30.22%
-4.30
60.08%
-0.23
94.66%
-0.01
96.88%
-0.00
81.37%
gross profit margin
1
-
1
-
1
0%
1
0%
1
0%
interest coverage
-3.22
-
-1.47
54.41%
-22.97
1,465.09%
-2.05K
8,822.12%
-1.60K
22.16%
3.07
100.19%
-1.39K
45,278.36%
-1.38K
0.52%
-205.94
85.07%
-2.58K
1,151.25%
inventory turnover
long term debt to capitalization
-0.60
-
-0.02
97.24%
-0.01
44.02%
0.02
305.61%
0.00
92.92%
0.00
33.75%
-1.85
207,971.67%
0.04
101.90%
0.04
10.10%
0.15
286.88%
0.01
90.95%
net income per ebt
1.00
-
1.00
0.07%
1.00
0.01%
1.00
0.02%
1.00
0.01%
1.00
0.01%
1.00
0.00%
1.00
0.00%
1.00
0.01%
1.00
0.00%
1
0.01%
net profit margin
-8.20
-
-16.46
-
-43.07
161.66%
260.66
705.17%
-27.59
110.59%
operating cash flow per share
-58.05
-
-62.99
8.51%
-81.60
29.54%
-28.93
64.55%
-19.56
32.37%
-15.26
22.01%
-10.78
29.38%
-4.21
60.97%
-0.23
94.56%
-0.01
96.87%
-0.00
81.33%
operating profit margin
-8.20
-
-16.46
-
-43.09
161.76%
260.75
705.17%
-31.03
111.90%
payables turnover
pretax profit margin
-8.20
-
-16.46
-
-43.07
161.68%
260.63
705.15%
-27.59
110.59%
price fair value
-0.79
-
-0.64
18.71%
-5.20
709.37%
23.97
561.36%
1.87
92.21%
5.37
187.48%
-3.37
162.75%
1.99
159.21%
113.80
5,605.43%
2.07K
1,722.27%
914.50
55.90%
receivables turnover
26.83
-
3.28
87.77%
-0.28
108.63%
return on assets
-11.25
-
-51.49
357.49%
-47.71
7.34%
-2.76
94.21%
-1.27
53.96%
-1.75
37.97%
-3.60
105.07%
-0.17
95.40%
-0.64
286.34%
-2.81
339.05%
-0.24
91.55%
return on capital employed
1.02
-
0.40
61.09%
22.18
5,501.71%
-4.37
119.71%
-1.45
66.92%
-2.19
51.48%
-6.93
216.45%
-0.17
97.51%
-0.69
302.62%
-3.59
417.14%
-0.28
92.23%
return on equity
0.23
-
0.68
191.54%
15.86
2,246.45%
-16.65
205.00%
-2.07
87.55%
-3.48
67.56%
3.63
204.33%
-0.19
105.38%
-0.74
278.52%
-4.90
564.55%
-0.26
94.76%
total debt to capitalization
-1.18
-
-2.27
93.05%
-0.02
98.91%
0.10
507.67%
0.01
90.66%
0.01
1.04%
-2.50
26,894.15%
0.04
101.56%
0.04
15.42%
0.18
309.76%
0.02
90.09%

All numbers in (except ratios and percentages)